Loading clinical trials...
Loading clinical trials...
Phase 3, Double-blind, Randomized, Active-controlled (Part 1) and Open-labeled, Historical Placebo Controlled (Part 2) Study to Evaluate the Efficacy of Hunterase (Idursulfase-beta) in Hunter Syndrome (Mucopolysaccharidosis II) Patients
Conditions
Interventions
GC1111
Comparator
Locations
1
South Korea
Samsug Medical Center
Seoul, South Korea
Start Date
March 9, 2017
Primary Completion Date
February 15, 2022
Completion Date
February 15, 2022
Last Updated
April 16, 2024
NCT05422482
NCT05795361
NCT01506141
NCT02412787
NCT05058391
NCT03582449
Lead Sponsor
Green Cross Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions